When: Reclaim of $90.69 (50 SMA) with positive MACD histogram

Then: Upgrade to Overweight at full benchmark weight

When: Pullback to $82-$84 zone with confirmed capitulation (RSI <30 + bullish divergence on daily)

Then: Scale into full benchmark weight

When: Confirmed close below $84.50 with volume >5M

Then: Exit residual entirely; wait for $82-84 structural floor defense

HOLD with 15-20% trim into rallies toward $87.41-$87.63; do not add; hold core position; revisit after Q3 earnings or confirmed reversal above $87.63 with volume

• 200 SMA breakdown at $86.15 is significant institutional flow trigger, not noise—pension funds, mutual funds, and risk-parity systems reduce exposure on closes below it
• MACD histogram improved from negative 0.39 to negative 0.17 but remains negative with MACD at negative 1.17 and signal at negative 1.00; price must reclaim 10 EMA at $87.63 before any bullish call
• FCF coverage is 1.9 times and dividend is safe, but 2.4% yield does not protect from 10-15% drawdown if technical breakdown extends to $83.50 or $80
• Goldman Sachs personal care divestiture is speculation with no announced transaction, no agreed price, and no closing timeline—building a position ahead of unconfirmed catalyst creates downside trap
• Forward P/E of 21 times in a 96% no-cut environment is full valuation; higher-for-longer rates put ceiling on multiples for a 3-4% revenue grower regardless of bond proxy framing
• Negative working capital of negative $1.14 billion is a leverage position that could reverse quickly if palm oil/packaging costs rise and retailers tighten payment terms
• CL gets cost pressure from geopolitical disruption without the defensive performance bid until the market actually breaks; additional 5-8% decline possible before flight to safety
• Tactical accumulation plan at $86.26 with stop at $84.79 miscalculates risk—realistic downside is 3.2% to $83.50 or 7.2% to $80, with 65% probability of bearish scenario; April swing low may not hold in different market regime
• Capital preservation is not the same as being bearish—quality compounder with safe dividend and improving balance sheet, but adding exposure with broken chart and hostile macro is precisely how a HOLD becomes regret

→ vs aggressive: 200 SMA 'noise' argument is wrong—8 out of 8 indicators confirming breakdown is regime change, not digestion; institutional triggers fire on below-200 SMA closes with elevated 6.9M share volume

→ vs aggressive: MACD 'higher lows' framing omits that histogram remains negative at -0.17, MACD at -1.17 is falling, and MACD signal at -1.00 has not crossed—'less bad' is not the same as bullish

→ vs aggressive: Dividend safety tells you the company survives, not that the multiple won't compress further when 200 SMA is lost, Fed isn't cutting, and input costs are worsening

→ vs aggressive: Goldman Sachs divestiture catalyst is speculation—building a position before deal announcement, price, and timeline is how you get stuck 4% lower when it fails or comes in below expectations

→ vs aggressive: Bond proxy framing cuts both ways—2.4% yield loses relative attractiveness when 10-year yields rise, creating valuation pressure regardless of operating fundamentals

→ vs aggressive: Negative working capital 'competitive advantage' framing ignores that negative $1.14 billion is supplier leverage that could reverse quickly if supplier credit events occur or retailers tighten terms

→ vs aggressive: Geopolitical tailwind thesis ignores that CL gets cost headwinds without defensive bid until market actually breaks—slow-burn cost pressure, not capital rotation catalyst

→ vs aggressive: Tactical accumulation math is flawed—realistic downside from $86.26 is 3.2% to $83.50 or 7.2% to $80, not 1.7% to April swing low; $1.62 ATR compressed moves that break often gap through prior support

HOLD the core position; if 200 SMA reclaims on volume at $87.41, add tactically toward $90; if $85.31 breaks on volume, trim 30% of position; collect the 2.4% dividend while waiting for price-based triggers

• 200 SMA at $87.41 is the trigger for any tactical add; current $1.15 below represents a warning but not a regime change in this 60% gross margin consumer staples franchise
• MACD histogram higher lows are early warning signals, not standalone trade triggers; wait for histogram to cross zero, MACD to cross signal, and price to reclaim 10 EMA
• Dividend is genuinely safe based on $3.46 billion trailing FCF coverage, but this protects income, not capital; 2.4% yield means being paid to wait
• Goldman Sachs divestiture is optionality, not a base case catalyst; no announced transaction, no agreed price, no closing timeline; treat as upside scenario, not reason to add
• 21x forward P/E already prices in the no-cut environment; this is fair value for a compounder with 60% gross margins and deleveraging balance sheet, not a reason to add or trim
• Negative working capital is a leverage position not fully controlled by management; tail risk rather than base case, not a position-sizing driver
• Aggressive add plan (25-30% dry powder at $86.26) fights the tape with all eight indicators bearish; ATR-based stop at $83.81 is more appropriate than the April swing low at $84.79
• Conservative trim plan (15-20% into $87.41-$87.63) overengineers the position; selling low in a quality compounder with safe dividend is a long-term underperformance strategy
• The chart is coiled with 2-4 week resolution window; $87.41 upside trigger and $85.31 downside trigger will provide clear directional signals without forcing a bet today

→ vs aggressive: Deploying 25-30% of dry powder on potential reversal setup works 40% of the time and gets stopped out 60% of the time; risk/reward underweights downside because $84.79 stop was set in different trend context and likely fails in current regime

→ vs conservative: Trimming a quality compounder with 130-year dividend record and fortress balance sheet means selling low and hoping to buy lower; trim contingent on rally to $87.41-$87.63 (major resistance where price has failed before) creates too many conditional 'ifs'